China-based physician networking service Medlinker launched a RMB500m ($76.3m) corporate venturing fund yesterday, DealStreetAsia reported.
Medlinker operates an online platform where doctors and other medical staff can connect and discuss work and cases. It plans to invest in companies developing technologies that can facilitate the management of chronic illnesses.
The vehicle has been established in partnership with investment firm Wuhan S&T Investment Company and an affiliate of financial services firm China Merchants Bank.
Areas of interest for the fund will include digital therapeutics and artificial intelligence-equipped medical devices and diagnostics tools, in addition to new models of care that can be provided outside of hospitals and clinics.
Medlinker had raised at least $246m in funding, as of a $146m series D round in mid-2018. Its investors include internet group Tencent and computing technology provider China Electronics Corporation.
